Since 1995, when for the first time the critical role of the phosphatidylinositol 3-kinase (PI3K) was discovered in the cellular trafficking events in the yeast (1), many studies have been conducted to determine the role of this kinase in eukaryotic cells, especially in human cancers. This evidence concerns the gene PIK3CG and cancer.